{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T16:36:13Z","timestamp":1793464573493,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T00:00:00Z","timestamp":1665100800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009139","name":"German Centre for Infection Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007131","name":"Texas Tech University","doi-asserted-by":"publisher","award":["05.715"],"award-info":[{"award-number":["05.715"]}],"id":[{"id":"10.13039\/100007131","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007131","name":"Texas Tech University","doi-asserted-by":"publisher","award":["05.813"],"award-info":[{"award-number":["05.813"]}],"id":[{"id":"10.13039\/100007131","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB-TRR 179\/2 2020 \\u2013272983813"],"award-info":[{"award-number":["SFB-TRR 179\/2 2020 \\u2013272983813"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TP18"],"award-info":[{"award-number":["TP18"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["272983813"],"award-info":[{"award-number":["272983813"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TRR179"],"award-info":[{"award-number":["TRR179"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"Horizon 2020","doi-asserted-by":"publisher","award":["848223"],"award-info":[{"award-number":["848223"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["AZ 031B0094C"],"award-info":[{"award-number":["AZ 031B0094C"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015754","name":"Stiftung der Deutschen Wirtschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015754","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012412","name":"Kansai Medical University","doi-asserted-by":"publisher","award":["StabVacHepB AZ 031B0094C"],"award-info":[{"award-number":["StabVacHepB AZ 031B0094C"]}],"id":[{"id":"10.13039\/501100012412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.jhepr.2022.100603","type":"journal-article","created":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T07:34:34Z","timestamp":1665646474000},"page":"100603","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Efficient stabilization of therapeutic hepatitis B vaccine components by amino-acid formulation maintains its potential to break immune tolerance"],"prefix":"10.1016","volume":"5","author":[{"given":"Julia","family":"Sacherl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6352-1415","authenticated-orcid":false,"given":"Anna D.","family":"Kosinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Kemter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"K\u00e4chele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine C.","family":"Laumen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7148-831X","authenticated-orcid":false,"given":"H\u00e9l\u00e8ne A.","family":"Kerth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edanur Ates","family":"\u00d6z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3406-4208","authenticated-orcid":false,"given":"Lisa S.","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinpeng","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Essbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Sutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Scholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2401-9104","authenticated-orcid":false,"given":"Katrin","family":"Singethan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Altrichter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9421-1911","authenticated-orcid":false,"given":"Ulrike","family":"Protzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2022.100603_bib1","series-title":"Global hepatitis report 2017","year":"2017"},{"key":"10.1016\/j.jhepr.2022.100603_bib2","first-page":"933","article-title":"Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope","volume":"180","author":"Bertoletti","year":"1994"},{"key":"10.1016\/j.jhepr.2022.100603_bib3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.iy.13.040195.000333","article-title":"Hepatitis B virus immunopathogenesis","volume":"13","author":"Chisari","year":"1995","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jhepr.2022.100603_bib4","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/S0016-5085(99)70289-1","article-title":"Direct\u00a0ex\u00a0vivo\u00a0analysis of hepatitis B virus-specific CD8+ T cells associated\u00a0with the control of infection","volume":"117","author":"Maini","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2022.100603_bib5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1053\/j.gastro.2018.10.032","article-title":"Targeting innate and adaptive immune responses to cure chronic HBV infection","volume":"156","author":"Gehring","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2022.100603_bib6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrgastro.2016.7","article-title":"Global strategies are required to cure and eliminate HBV infection","volume":"13","author":"Revill","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2022.100603_bib7","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1751-7915.2011.00303.x","article-title":"Design of therapeutic vaccines: hepatitis B as an example","volume":"5","author":"Kutscher","year":"2012","journal-title":"Microb Biotechnol"},{"key":"10.1016\/j.jhepr.2022.100603_bib8","first-page":"923","article-title":"Protein-prime\/modified vaccinia virus Ankara vector-boost vaccination overcomes tolerance in high-antigenemic HBV-transgenic mice","volume":"34","author":"Backes","year":"2016"},{"key":"10.1016\/j.jhepr.2022.100603_bib9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.coviro.2017.03.011","article-title":"Therapeutic vaccination for chronic hepatitis B","volume":"23","author":"Kosinska","year":"2017","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.jhepr.2022.100603_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-47149-w","article-title":"Synergy of therapeutic heterologous prime-boost hepatitis B vaccination with CpG-application to improve immune control of persistent HBV infection","volume":"9","author":"Kosinska","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2022.100603_bib11","article-title":"Costs of introducing and delivering HPV vaccines in low and lower middle income countries: inputs for GAVI policy on introduction grant support to countries","volume":"9","author":"Levin","year":"2014"},{"key":"10.1016\/j.jhepr.2022.100603_bib12","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1586\/erv.09.20","article-title":"Opportunities and challenges of developing thermostable vaccines","volume":"8","author":"Chen","year":"2009","journal-title":"Expert Rev Vaccin"},{"key":"10.1016\/j.jhepr.2022.100603_bib13","series-title":"Meeting report. WHO\/Paul-Ehrlich-Institut informal consultation on scientific and regulatory considerations on the stability evaluation of vaccines under controlled temperature chain (CTC)","year":"2013"},{"key":"10.1016\/j.jhepr.2022.100603_bib14","series-title":"Temperature sensitivity of vaccines","year":"2006"},{"key":"10.1016\/j.jhepr.2022.100603_bib15","series-title":"Annex 5. Guidelines on the stability evaluation of vaccines for use under extended controlled temperature conditions","year":"2006"},{"key":"10.1016\/j.jhepr.2022.100603_bib16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-1-61779-876-4_4","article-title":"Easy and efficient protocols for working with recombinant vaccinia virus MVA","volume":"890","author":"Kremer","year":"2012","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jhepr.2022.100603_bib17","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/j.gastro.2007.11.002","article-title":"T\u00a0cells redirected against hepatitis B virus surface proteins eliminate infected hepatocytes","volume":"134","author":"Bohne","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2022.100603_bib18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.antiviral.2017.06.013","article-title":"Construction of a hepatitis B virus neutralizing chimeric monoclonal antibody recognizing escape mutants of the viral surface antigen (HBsAg)","volume":"144","author":"Golsaz-Shirazi","year":"2017","journal-title":"Antivir Res"},{"key":"10.1016\/j.jhepr.2022.100603_bib19","doi-asserted-by":"crossref","first-page":"5554","DOI":"10.1128\/JVI.03134-12","article-title":"Adeno-associated virus-mediated gene transfer leads to persistent hepatitis B virus replication in mice expressing HLA-A2 and HLA-DR1 molecules","volume":"87","author":"Dion","year":"2013","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jhepr.2022.100603_bib20","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/hep.25765","article-title":"Foxp3+ regulatory T cells protect the liver from immune damage and compromise virus control during acute experimental hepatitis B virus infection in mice","volume":"56","author":"Stross","year":"2012","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jhepr.2022.100603_bib21","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1053\/j.gastro.2020.01.032","article-title":"Knockdown of virus antigen expression increases therapeutic vaccine efficacy in high-titer hepatitis B virus carrier mice","volume":"158","author":"Michler","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2022.100603_bib22","article-title":"Immunogenicity and antiviral response of therapeutic hepatitis B vaccination in a mouse model of HBeAg-negative, persistent HBV infection","volume":"vol. 9","author":"Kosinska","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jhepr.2022.100603_bib23","series-title":"Stability testing of new drug substances and pruducts Q1A(R2). step 4 version","year":"2003"},{"key":"10.1016\/j.jhepr.2022.100603_bib24","series-title":"WHO expert committee on specifications for pharmaceutical preparations","year":"2009"},{"key":"10.1016\/j.jhepr.2022.100603_bib25","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.vaccine.2009.11.024","article-title":"Heat-stable measles vaccine produced by spray drying","volume":"28","author":"Ohtake","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jhepr.2022.100603_bib26","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ejpb.2019.01.019","article-title":"Thermostable Ebola virus vaccine formulations lyophilized in the presence of aluminum hydroxide","volume":"136","author":"Chisholm","year":"2019","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.jhepr.2022.100603_bib27","article-title":"Thermal stabilization of viral vaccines in low-cost sugar films","volume":"9","author":"Leung","year":"2019","journal-title":"Scientific Rep"},{"key":"10.1016\/j.jhepr.2022.100603_bib28","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.vaccine.2014.01.077","article-title":"Induction of protective immunity against H1N1 influenza A(H1N1)pdm09 with spray-dried and electron-beam sterilised vaccines in non-human primates","volume":"32","author":"Scherliess","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.jhepr.2022.100603_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/biot.201700523","article-title":"Amino acid-based advanced liquid formulation development for\u00a0highly\u00a0concentrated therapeutic antibodies balances physical\u00a0and\u00a0chemical stability and low viscosity","volume":"13","author":"Kemter","year":"2018","journal-title":"Biotechnol J"},{"key":"10.1016\/j.jhepr.2022.100603_bib30","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.xphs.2019.10.063","article-title":"Algorithm-based liquid formulation development including a DoE concept predicts long-term viral vector stability","volume":"109","author":"Reinauer","year":"2020","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.jhepr.2022.100603_bib31","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejps.2014.01.005","article-title":"Improved storage stability and immunogenicity of hepatitis B vaccine after spray-freeze drying in presence of sugars","volume":"55","author":"Tonnis","year":"2014","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.jhepr.2022.100603_bib32","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s11095-009-0045-6","article-title":"Stability of protein pharmaceuticals: an update","volume":"27","author":"Manning","year":"2010","journal-title":"Pharm Res"},{"key":"10.1016\/j.jhepr.2022.100603_bib33","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.xphs.2015.11.002","article-title":"Immunogenicity of therapeutic protein aggregates","volume":"105","author":"Moussa","year":"2016","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.jhepr.2022.100603_bib34","doi-asserted-by":"crossref","first-page":"E501","DOI":"10.1208\/aapsj080359","article-title":"Effects of protein aggregates: an immunologic perspective","volume":"8","author":"Rosenberg","year":"2006","journal-title":"AAPS J"},{"key":"10.1016\/j.jhepr.2022.100603_bib35","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/jps.21433","article-title":"Influence of protein conformation and adjuvant aggregation on the effectiveness of aluminum hydroxide adjuvant in a model alkaline phosphatase vaccine","volume":"98","author":"Clausi","year":"2009","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.jhepr.2022.100603_bib36","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1073\/pnas.1500475112","article-title":"Initial viral load determines the magnitude of the human CD8 T cell response to yellow fever vaccination","volume":"112","author":"Akondy","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhepr.2022.100603_bib37","series-title":"Modified Vaccinia virus Ankara","first-page":"187","author":"Volz","year":"2017"},{"key":"10.1016\/j.jhepr.2022.100603_bib38","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1016\/j.vaccine.2012.02.016","article-title":"Biosafety aspects of modified vaccinia virus Ankara (MVA)-based vectors used for gene therapy or vaccination","volume":"30","author":"Verheust","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jhepr.2022.100603_bib39","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/jmv.10509","article-title":"Cytokine-dependent anti-viral role of CD4-positive T cells in therapeutic vaccination against chronic hepatitis B viral infection","volume":"71","author":"Ren","year":"2003","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.jhepr.2022.100603_bib40","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1016\/S0264-410X(02)00309-2","article-title":"Immunological monitoring during therapeutic vaccination as a prerequisite for the design of new effective therapies: induction of a vaccine-specific CD4+ T-cell proliferative response in chronic hepatitis B carriers","volume":"20","author":"Jung","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.jhepr.2022.100603_bib41","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0264-410X(88)90137-5","article-title":"Immunogenicity of a heat-treated recombinant DNA hepatitis B vaccine","volume":"6","author":"Just","year":"1988","journal-title":"Vaccine"},{"key":"10.1016\/j.jhepr.2022.100603_bib42","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0264-410X(92)90064-Q","article-title":"Heat stability of a recombinant DNA hepatitis B vaccine","volume":"10","author":"Van Damme","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.jhepr.2022.100603_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20205080","article-title":"The good and the bad of natural killer cells in virus control: perspective for anti-HBV therapy","volume":"20","author":"Fisicaro","year":"2019","journal-title":"Int J Mol Sci"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555922001756?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555922001756?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:07:09Z","timestamp":1778904429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555922001756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S2589555922001756"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2022.100603","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficient stabilization of therapeutic hepatitis B vaccine components by amino-acid formulation maintains its potential to break immune tolerance","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2022.100603","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"100603"}}